Aceso Life Science Group Limited

Symbol: 0474.HK




Market price today

  • -1.7896

    P/E Ratio

  • -0.1738

    PEG Ratio

  • 1.16B

    MRK Cap

  • 0.00%

    DIV Yield

Aceso Life Science Group Limited (0474-HK) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Industrials
Industry: Conglomerates
Full-time employees:142
City:Wan Chai
Address:Rooms 2501–2509, Shui On Centre

Aceso Life Science Group Limited, an investment holding company, engages in money lending, securities investment, asset management, rental, and trading of construction machinery, repair and maintenance and transportation service, property leasing and development, and bioscience businesses. The company also provides commodities, futures, securities brokerage, and financial services, as well as rents and trades in construction machinery, including crawler cranes, other mobile cranes, aerial platforms, and foundation equipment, and spare parts. It offers repair and maintenance services for construction machinery; and transportation services, such as local container delivery, construction site delivery, and heavy machinery transport. In addition, the company retails men, and women apparels; sells construction materials; and offers management services. The company operates in Hong Kong, Macau, Cambodia, the United Kingdom, and the People's Republic of China. Aceso Life Science Group Limited was incorporated in 2005 and is based in Wan Chai, Hong Kong.

General Outlook

When we look at how much money they make before expenses, they keep 0.489% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.300%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.712%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.119% return, is a testament to Aceso Life Science Group Limited's adeptness in optimizing resource deployment. Aceso Life Science Group Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.447%. Furthermore, the proficiency of Aceso Life Science Group Limited in capital utilization is underscored by a remarkable -0.037% return on capital employed.

Stock Prices

Aceso Life Science Group Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.153, while its low point bottomed out at $0.142. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Aceso Life Science Group Limited's stock market.

Liquidity Ratios

Analyzing 0474.HK liquidity ratios reveals its financial health of the firm. The current ratio of 63.25% gauges short-term asset coverage for liabilities. The quick ratio (42.26%) assesses immediate liquidity, while the cash ratio (5.69%) indicates cash reserves.

Current Ratio63.25%
Quick Ratio42.26%
Cash Ratio5.69%

Profitability Ratios

0474.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -137.64% underscores its earnings before tax deductions. The effective tax rate stands at 1.48%, revealing its tax efficiency. The net income per EBT, 124.38%, and the EBT per EBIT, 458.37%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -30.03%, we grasp its operational profitability.

Pretax Profit Margin-137.64%
Effective Tax Rate1.48%
Net Income per EBT124.38%
EBT per EBIT458.37%
EBIT per Revenue-30.03%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.63, it details the span from stock purchase to revenue.

Days of Sales Outstanding42
Days of Inventory Outstanding645
Operating Cycle1264.48
Days of Payables Outstanding16
Cash Conversion Cycle1249
Receivables Turnover0.59
Payables Turnover23.50
Inventory Turnover0.57
Fixed Asset Turnover1.35
Asset Turnover0.07

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.06, and free cash flow per share, 0.05, depict cash generation on a per-share basis. The cash per share value, 0.05, showcases liquidity position. Lastly, the operating cash flow sales ratio, 1.28, offers insight into cash flow relative to sales.

Operating Cash Flow per Share0.06
Free Cash Flow per Share0.05
Cash per Share0.05
Operating Cash Flow Sales Ratio1.28
Free Cash Flow to Operating Cash Flow Ratio0.84
Cash Flow Coverage Ratio0.21
Short Term Coverage Ratio0.22
Capital Expenditure Coverage Ratio6.27
Dividend Paid and Capex Coverage Ratio6.27

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 42.80%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.78, we discern the balance between debt and equity financing. The long-term debt to capitalization, 9.98%, and total debt to capitalization, 64.08%, ratios shed light on its capital structure. An interest coverage of -0.76 indicates its ability to manage interest expenses.

Debt Ratio42.80%
Debt Equity Ratio1.78
Long Term Debt to Capitalization9.98%
Total Debt to Capitalization64.08%
Interest Coverage-0.76
Cash Flow to Debt Ratio0.21
Company Equity Multiplier4.17

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -8.96%, indicates top-line expansion, while the gross profit growth, -23.94%, reveals profitability trends. EBIT growth, -79.02%, and operating income growth, -79.02%, offer insights into operational profitability progression. The net income growth, -71.26%, showcases bottom-line expansion, and the EPS growth, -55.74%, measures the growth in earnings per share.

Revenue Growth-8.96%
Gross Profit Growth-23.94%
EBIT Growth-79.02%
Operating Income Growth-79.02%
Net Income Growth-71.26%
EPS Growth-55.74%
EPS Diluted Growth-61.49%
Weighted Average Shares Growth9.82%
Weighted Average Shares Diluted Growth6.06%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth76.54%
Free Cash Flow Growth57.93%
10-Year Revenue Growth per Share-69.48%
5-Year Revenue Growth per Share-35.28%
3-Year Revenue Growth per Share-32.43%
10-Year Operating CF Growth per Share150.09%
5-Year Operating CF Growth per Share337.52%
3-Year Operating CF Growth per Share358.08%
10-Year Net Income Growth per Share70.38%
5-Year Net Income Growth per Share9.17%
3-Year Net Income Growth per Share-7.26%
10-Year Shareholders Equity Growth per Share-91.06%
5-Year Shareholders Equity Growth per Share-51.37%
3-Year Shareholders Equity Growth per Share-47.84%
Receivables Growth50.26%
Inventory Growth-93.18%
Asset Growth1.59%
Book Value per Share Growth-23.47%
Debt Growth9.10%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.89, and the price to book ratio, 0.89, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.06, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 2.85, and price to operating cash flows, 2.40, gauge market valuation against cash flow metrics.

Price Book Value Ratio0.89
Price to Book Ratio0.89
Price to Sales Ratio3.06
Price Cash Flow Ratio2.40
Price Earnings to Growth Ratio-0.17
Enterprise Value Multiple5.03
Price Fair Value0.89
Price to Operating Cash Flow Ratio2.40
Price to Free Cash Flows Ratio2.85
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Aceso Life Science Group Limited (0474.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -1.790 in 2024.

What is the ticker symbol of Aceso Life Science Group Limited stock?

The ticker symbol of Aceso Life Science Group Limited stock is 0474.HK.

What is company IPO date?

IPO date of Aceso Life Science Group Limited is 2006-06-06.

What is company current share price?

Current share price is 0.160 HKD.

What is stock market cap today?

The market cap of stock today is 1163876800.000.

What is PEG ratio in 2024?

The current -0.174 is -0.174 in 2024.

What is the number of employees in 2024?

In 2024 the company has 142.